Artritis reumatoidea
Chalem, Fernando; Agudelo, Carlos; Escandón, Jaime; Starusta, Ptrez; Iglesias Gamarra, Antonio; Molina, Javier.
Acta méd. colomb
; 9(5): 213-29, sept.-oct. 1984. tab
Artículo en Español | LILACS | ID: lil-32673
Documentos relacionados
Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications.
The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
Gold-induced colitis: a case report and review of the literature.
Initial experience with oral gold salts in the treatment of rheumatoid arthritis in patients followed up for one year.
Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
Auranofin versus placebo in the treatment of rheumatoid arthritis.
Gold excretion and retention during auranofin treatment: a preliminary report.
Current status of disease-modifying drugs in progressive rheumatoid arthritis.